Abstract
P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
Highlights
AIDS Vaccine 2009 Anna Laura Ross Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf
HIV-1 diversity is considered a major hurdle for the successful design of a vaccine as well as for the development of reagents to assess vaccine efficacy
The aim of the present study is to evaluate the variability of Gag and Nef immunodominant regions previously described in HIV positive Brazilian individuals infected with B and F1 subtypes
Summary
Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes. Address: Laboratory of Aids and Molecular Immunology, Fiocruz, Rio de Janeiro, Brazil * Corresponding author from AIDS Vaccine 2009 Paris, France. Published: 22 October 2009 Retrovirology 2009, 6(Suppl 3):P388 doi:10.1186/1742-4690-6-S3-P388. AIDS Vaccine 2009 Anna Laura Ross Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
